Drug-of-Choice / Condition-Based Drug Selection
1. What this chapter covers, and how NEET PG actually tests it
Drug-of-choice questions are among the most common in the paper, and they are usually revised as flat lists.
That is the wrong model. A drug becomes the drug of choice for one of four reasons, and identifying which reason applies answers the question faster than recall does.
Reason one: it is uniquely effective, doing something no alternative does. Primaquine clears hypnozoites; nothing else in common use does.
Reason two: it is uniquely safe in this patient, where equally effective alternatives are contraindicated. Labetalol in pregnancy is chosen on safety, not potency.
Reason three: it covers the whole problem at once, where alternatives address only part. Adrenaline in anaphylaxis is the standing example.
Reason four: it is the only thing that reaches the target, whether that is a body compartment or an organism.
| Situation type | The deciding factor | Example |
|---|---|---|
| Unique mechanism | Nothing else does this | Primaquine for hypnozoites |
| Patient safety | Alternatives contraindicated | Labetalol in pregnancy |
| Complete coverage | Others address only part | Adrenaline in anaphylaxis |
| Access to target | Penetration or spectrum | Rifampicin for meningococcal carriage |
When a stem gives you a comorbidity, a pregnancy, an organ failure or an age, it is signalling reason two.
2. Selection by patient state
2.1 Pregnancy
Pregnancy questions are decided almost entirely by fetal safety, since maternal efficacy is usually comparable across options.
| Condition | Drug of choice | Avoid |
|---|---|---|
| Hypertension | Labetalol, methyldopa, nifedipine | ACE inhibitors, ARBs |
| Eclampsia prophylaxis and treatment | Magnesium sulphate | Diazepam, phenytoin |
| Hyperthyroidism, first trimester | Propylthiouracil | Carbimazole |
| Epilepsy | Lamotrigine, levetiracetam | Valproate |
| Deep vein thrombosis | Low molecular weight heparin | Warfarin |
| Urinary infection | Nitrofurantoin or cephalexin | Fluoroquinolones, co-trimoxazole |
| Diabetes | Insulin | Most oral agents |
Magnesium sulphate is superior to anticonvulsants in eclampsia, which is counterintuitive until you recognise that eclamptic seizures are not ordinary epilepsy and respond to a mechanism that antiepileptics do not provide.
Heparin is used in pregnancy because it does not cross the placenta, a molecular size argument rather than a toxicity one.
2.2 Renal and hepatic impairment
In renal impairment, the maintenance dose falls while the loading dose does not, and drugs cleared hepatically become preferable.
Doxycycline over other tetracyclines, and fentanyl over morphine, are both examples of choosing the hepatically cleared member of a class.
In liver disease, drugs undergoing conjugation only are preferred, which is why lorazepam, oxazepam and temazepam are the benzodiazepines of choice.
In both settings the choice is made by clearance route rather than by efficacy, which is a reliable shortcut in these stems.
2.3 When an existing drug decides the choice
A second common framing gives the patient a drug they are already taking, and the interaction rather than the disease decides the answer.
Any stem naming warfarin, digoxin, lithium, phenytoin, ciclosporin or an antiretroviral is inviting you to check the interaction before choosing.
A patient on warfarin who needs an antibiotic should not receive co-trimoxazole or a macrolide, both of which raise the international normalised ratio sharply.
A patient on clopidogrel who needs acid suppression should receive pantoprazole rather than omeprazole, since omeprazole inhibits the CYP2C19 activation step.
A patient on a statin who needs an antifungal should not receive an azole, because inhibited statin metabolism causes rhabdomyolysis.
A patient on lithium who needs analgesia should receive paracetamol rather than a non-steroidal anti-inflammatory drug, which raises lithium levels.
These are not obscure pairings; they are the specific combinations the exam reuses, because each has caused real harm.
2.4 Age extremes
Neonates lack mature glucuronidation, which is why chloramphenicol causes grey baby syndrome and why sulphonamides risk kernicterus.
In the elderly, reduced renal clearance, reduced phase I metabolism and greater central nervous system sensitivity all argue for lower starting doses.
Anticholinergic burden matters disproportionately in older patients, which is why tricyclics and first-generation antihistamines are avoided.
3. Emergency and acute presentations
3.1 The immediate decisions
| Emergency | Drug of choice | Why |
|---|---|---|
| Anaphylaxis | Intramuscular adrenaline | Covers all four components at once |
| Status epilepticus | Benzodiazepine first | Fastest reliable termination |
| Eclampsia | Magnesium sulphate | Superior to anticonvulsants |
| Supraventricular tachycardia | Adenosine | Transient AV block, half-life in seconds |
| Torsades de pointes | Magnesium sulphate | Effective regardless of magnesium level |
| Malignant hyperthermia | Dantrolene | Blocks calcium release from sarcoplasmic reticulum |
| Neuroleptic malignant syndrome | Dantrolene, bromocriptine | Muscle and dopamine limbs |
| Serotonin syndrome | Cyproheptadine | Serotonin antagonism |
| Cyanide poisoning | Hydroxocobalamin | Binds cyanide directly |
| Organophosphate poisoning | Atropine plus pralidoxime | Muscarinic and nicotinic limbs |
Magnesium works in torsades regardless of the serum magnesium level, which is why the level should not be checked before treating.
Dantrolene appears twice because both malignant hyperthermia and neuroleptic malignant syndrome share uncontrolled muscle calcium release as their lethal mechanism.
3.2 Poisoning and its logic
Antidotes fall into three mechanistic groups, and recognising the group makes them derivable.
Some replace what has been depleted, as N-acetylcysteine replaces glutathione.
Some compete at the receptor, as naloxone and flumazenil do.
Some bind or convert the poison, as desferrioxamine, digoxin antibody fragments and hydroxocobalamin do.
Fomepizole belongs to a fourth pattern, blocking the enzyme that generates the toxic metabolite rather than the parent compound, which is why it works in both methanol and ethylene glycol poisoning.
In each of those poisonings the parent alcohol is relatively harmless and the metabolite does the damage, so inhibiting alcohol dehydrogenase buys time for the parent to be excreted unchanged.
Ethanol achieves the same thing by competing for the enzyme, which is why it was used before fomepizole was available.
Recognising which group an antidote belongs to also predicts its limitations: a competitive antagonist such as naloxone wears off faster than the opioid it reverses, whereas a binding agent such as digoxin antibody removes the drug permanently.
That difference is why naloxone may need an infusion while digoxin antibody is given once.
4. Infection: matching organism to agent
4.1 The standing associations
| Infection | Drug of choice |
|---|---|
| Streptococcal pharyngitis | Penicillin |
| Syphilis | Benzathine penicillin |
| MRSA | Vancomycin |
| Pseudomonas | Antipseudomonal beta-lactam, often combined |
| Atypical pneumonia | Macrolide or doxycycline |
| Anaerobic infection | Metronidazole |
| Clostridioides difficile | Oral vancomycin or fidaxomicin |
| Pneumocystis pneumonia | Co-trimoxazole |
| Meningococcal prophylaxis | Rifampicin or ciprofloxacin |
| Scrub typhus and rickettsiae | Doxycycline |
| Severe falciparum malaria | Artesunate |
| Amoebic liver abscess | Metronidazole then a luminal agent |
| Herpes encephalitis | Aciclovir |
| Cerebral toxoplasmosis | Pyrimethamine with sulphadiazine |
Syphilis is the standing example of an organism that has never developed penicillin resistance, which is why penicillin remains the answer decades on and why penicillin desensitisation is performed in allergic pregnant women rather than substituting another agent.
Oral vancomycin is used in Clostridioides difficile precisely because it is not absorbed, so it reaches high colonic concentration while intravenous vancomycin would not work at all.
That inversion — a drug chosen because it is poorly absorbed — is a favourite examination point.
4.2 Prophylaxis versus treatment
The drug that treats an infection is often not the drug that prevents it, because prophylaxis has different requirements.
Rifampicin or ciprofloxacin is used for meningococcal contact prophylaxis because both eradicate nasopharyngeal carriage, which ceftriaxone treatment of the case does not reliably do.
Surgical prophylaxis uses a first-generation cephalosporin given within an hour of incision, since the goal is tissue concentration at the moment of contamination.
Prophylaxis is a question about timing and site, not about killing power, and reading it that way resolves most such stems.
4.3 When the drug of choice cannot be used
A second layer of questions asks what to give when the first choice is contraindicated, and the substitute is rarely arbitrary.
| First choice | Blocked by | Substitute |
|---|---|---|
| Penicillin | Mild allergy | Cephalosporin or macrolide |
| Penicillin | Severe anaphylaxis | Macrolide, clindamycin, or aztreonam for Gram-negatives |
| ACE inhibitor | Cough | Angiotensin receptor blocker |
| ACE inhibitor | Angioedema | Neither class; use a calcium channel blocker |
| Beta blocker | Asthma | Cardioselective agent, or a calcium channel blocker |
| Warfarin | Pregnancy | Low molecular weight heparin |
| Metformin | Renal impairment or contrast | Withhold; a DPP-4 inhibitor is often used |
| Aspirin | True allergy | Clopidogrel |
Angioedema on an ACE inhibitor is the one that trips candidates, because the obvious substitution to an angiotensin receptor blocker is unsafe: although the mechanism differs, angioedema has been reported with that class too and the risk is not worth taking.
Cough, by contrast, is purely a bradykinin effect and switching to an angiotensin receptor blocker is entirely appropriate.
That difference — same drug, two side effects, two different answers — is exactly the kind of distinction the exam is built on.
5. Chronic disease and the outcome question
5.1 When the question is really about mortality
Many chronic disease selection questions are asking which drug changes outcome, not which relieves symptoms.
In heart failure, ACE inhibitors, beta blockers, mineralocorticoid antagonists, sacubitril-valsartan and SGLT2 inhibitors prolong life while diuretics and digoxin do not.
In diabetes with cardiovascular or renal disease, SGLT2 inhibitors and GLP-1 agonists are chosen on outcome data rather than glucose lowering.
In chronic obstructive pulmonary disease, only smoking cessation and long-term oxygen in hypoxaemic patients alter survival.
Whenever a stem uses the words prognosis, survival or mortality, the symptom-relieving option is a distractor.
5.2 Condition-based selections worth knowing
| Condition | Drug of choice |
|---|---|
| Absence seizures | Ethosuximide or valproate |
| Trigeminal neuralgia | Carbamazepine |
| Neuropathic pain | Amitriptyline, gabapentin, pregabalin, duloxetine |
| Acute gout | NSAID or colchicine; steroids if both contraindicated |
| Chronic gout prophylaxis | Allopurinol, started after the attack settles |
| Wilson disease | Penicillamine or trientine |
| Myasthenia gravis | Pyridostigmine |
| Prolactinoma | Cabergoline |
| Acromegaly, medical | Octreotide |
| Bipolar maintenance | Lithium |
| Obsessive-compulsive disorder | SSRI at higher dose |
| Alcohol withdrawal | Chlordiazepoxide with thiamine |
| Opioid maintenance | Methadone or buprenorphine |
Allopurinol is started only after an acute attack has settled, because the sudden fall in urate mobilises crystals and can precipitate a further attack.
That same principle explains why urate-lowering therapy is introduced under colchicine or non-steroidal cover.
Carbamazepine in trigeminal neuralgia is another selection made on unique effectiveness rather than on it being an anticonvulsant, since ordinary analgesics are largely useless in that condition.
Neuropathic pain generally does not respond to conventional analgesics either, which is why the drugs of choice for it come from the antidepressant and antiepileptic classes instead.
Recognising that a pain is neuropathic therefore changes the entire drug list, and the stem usually signals it with burning, shooting or electric-shock descriptions.
Lithium remains the drug of choice for bipolar maintenance because it is the only mood stabiliser with clear evidence of reducing suicide risk, which is a mortality argument rather than a symptomatic one.
5.3 Gastrointestinal, respiratory and skin
These are examined less heavily but the associations are fixed and cheaply learned.
| Condition | Drug of choice |
|---|---|
| Peptic ulcer with Helicobacter | Triple therapy: proton pump inhibitor with two antibiotics |
| Ulcerative colitis, mild | Mesalazine |
| Crohn disease, induction | Corticosteroid |
| Hepatic encephalopathy | Lactulose, with rifaximin added |
| Acute severe asthma | Nebulised salbutamol with systemic steroid |
| Asthma maintenance | Inhaled corticosteroid, never a bronchodilator alone |
| COPD maintenance | Long-acting bronchodilators |
| Anaphylactic laryngeal oedema | Adrenaline |
| Scabies | Permethrin, ivermectin if widespread |
| Severe psoriasis | Methotrexate or a biologic |
| Acne, severe nodulocystic | Isotretinoin |
Lactulose works in hepatic encephalopathy by acidifying the colon so ammonia is converted to poorly absorbed ammonium and trapped there, which is ion trapping applied deliberately rather than as a poisoning phenomenon.
An inhaled corticosteroid is the maintenance choice in asthma because the disease is inflammatory, and using a long-acting bronchodilator alone has been shown to increase mortality by masking deteriorating inflammation.
That mortality signal is why long-acting bronchodilators are never prescribed without an inhaled steroid in asthma, though they are appropriate alone in chronic obstructive pulmonary disease.
6. Worked examples
Example 1
A 28-year-old at 32 weeks with severe pre-eclampsia has a generalised seizure. Which drug should be given?
The instinct is to reach for an anticonvulsant, since the presentation is a seizure.
Eclamptic seizures are not epileptic in mechanism, and magnesium sulphate has been shown superior to both diazepam and phenytoin for controlling them and preventing recurrence.
Magnesium also reduces the risk of recurrent seizures more effectively than either alternative, which is what makes it the answer rather than merely an option.
Monitoring is by reflexes, respiratory rate and urine output, with calcium gluconate as the antidote for toxicity.
Loss of deep tendon reflexes is the earliest sign of magnesium toxicity and precedes respiratory depression, which is why reflexes are checked before each further dose.
Example 2
A patient with Clostridioides difficile colitis is prescribed intravenous vancomycin and does not improve.
The drug is correct but the route defeats it.
Vancomycin is very poorly absorbed from the gut, which is normally a limitation but here is precisely the property being exploited.
Given orally it reaches high concentration in the colonic lumen where the organism is; given intravenously it barely enters the bowel lumen at all.
Oral vancomycin or fidaxomicin is required, and metronidazole is now generally reserved for milder or resource-limited settings.
Example 3
A woman with confirmed syphilis in the second trimester reports a penicillin allergy. What is the correct approach?
Doxycycline, the usual alternative in a non-pregnant patient, is contraindicated in pregnancy.
Macrolides do not reliably cross the placenta in sufficient concentration to treat the fetus, so the fetus would remain untreated.
Penicillin remains the only agent that reliably treats both mother and fetus, so the correct approach is penicillin desensitisation rather than substitution.
This is one of the clearest examples in medicine of the drug of choice being non-negotiable because no alternative reaches the target.
7. Traps the exam sets repeatedly
Treating eclampsia with a conventional anticonvulsant. Magnesium sulphate is superior and is the answer.
Giving intravenous vancomycin for Clostridioides difficile. The oral route is required because poor absorption is the point.
Starting allopurinol during an acute gout attack. Mobilising urate can worsen the attack; wait until it settles.
Offering a symptomatic drug when the question asks about mortality. Diuretics and digoxin improve symptoms in heart failure without prolonging life.
Substituting another antibiotic for penicillin in syphilis in pregnancy. Desensitisation is preferred because no alternative reliably treats the fetus.
Switching to an angiotensin receptor blocker after ACE inhibitor angioedema. Cough justifies the switch; angioedema does not, and neither class should be used.
Prescribing a long-acting bronchodilator alone in asthma. It masks worsening inflammation and increases mortality; an inhaled corticosteroid is always required alongside.
Choosing an antibiotic in a warfarinised patient without checking the interaction. Co-trimoxazole and macrolides both raise the international normalised ratio sharply.
Summary
A drug becomes the drug of choice for one of four reasons, and identifying the reason is faster than recall.
A stated comorbidity, pregnancy, organ failure or age in the stem is signalling that safety rather than efficacy decides the answer.
Pregnancy selections are driven by fetal safety, and heparin is used because it does not cross the placenta.
In organ impairment, the clearance route rather than the efficacy decides which member of a class is chosen.
Magnesium sulphate is the answer in both eclampsia and torsades de pointes, and in torsades the serum level is irrelevant.
Dantrolene treats both malignant hyperthermia and neuroleptic malignant syndrome because both involve uncontrolled muscle calcium release.
Antidotes fall into groups that replace, compete, bind or block metabolite formation, which makes them derivable.
Oral vancomycin works in Clostridioides difficile because it is not absorbed, an inversion the exam favours.
Prophylaxis is a question about timing and site rather than killing power.
A named existing drug in a stem is usually an interaction question in disguise.
ACE inhibitor cough justifies switching to an angiotensin receptor blocker; angioedema rules out both classes.
Lactulose treats hepatic encephalopathy by trapping ammonia as ammonium in an acidified colon.
When a stem mentions prognosis or mortality, the symptom-relieving option is a distractor.
